Slc2a3 Rat (-)-demecolcine increases expression ISO SLC2A3 (Homo sapiens) 6480464 Demecolcine results in increased expression of SLC2A3 mRNA CTD PMID:23649840 Slc2a3 Rat (-)-epigallocatechin 3-gallate increases expression ISO SLC2A3 (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of SLC2A3 mRNA and epigallocatechin gallate results in increased expression of SLC2A3 protein CTD PMID:31857147 Slc2a3 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC2A3 mRNA more ... CTD PMID:22079256 and PMID:31857147 Slc2a3 Rat 1,2-dimethylhydrazine multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SLC2A3 mRNA CTD PMID:22206623 Slc2a3 Rat 1,2-dimethylhydrazine increases expression ISO Slc2a3 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of SLC2A3 mRNA CTD PMID:22206623 Slc2a3 Rat 1,4-phenylenediamine increases expression ISO SLC2A3 (Homo sapiens) 6480464 4-phenylenediamine results in increased expression of SLC2A3 mRNA CTD PMID:19371601 Slc2a3 Rat 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 chlorcyclizine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 Slc2a3 Rat 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Citalopram results in decreased expression of SLC2A3 mRNA CTD PMID:17567588 Slc2a3 Rat 1-chloro-2,4-dinitrobenzene decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Dinitrochlorobenzene results in decreased expression of SLC2A3 mRNA CTD PMID:19371601 Slc2a3 Rat 1-chloro-2,4-dinitrobenzene increases expression ISO SLC2A3 (Homo sapiens) 6480464 Dinitrochlorobenzene results in increased expression of SLC2A3 mRNA CTD PMID:17374397 Slc2a3 Rat 1-fluoro-2,4-dinitrobenzene increases expression ISO SLC2A3 (Homo sapiens) 6480464 Dinitrofluorobenzene results in increased expression of SLC2A3 mRNA CTD PMID:21362464 Slc2a3 Rat 17beta-estradiol decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Estradiol results in decreased expression of SLC2A3 mRNA CTD PMID:20106945 and PMID:21632981 Slc2a3 Rat 17beta-estradiol multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC2A3 mRNA CTD PMID:30165855 Slc2a3 Rat 17beta-estradiol 3-benzoate decreases methylation EXP 6480464 estradiol 3-benzoate results in decreased methylation of SLC2A3 promoter CTD PMID:27415467 Slc2a3 Rat 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO SLC2A3 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of SLC2A3 mRNA CTD PMID:29581250 Slc2a3 Rat 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO Slc2a3 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 Slc2a3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc2a3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC2A3 protein CTD PMID:17872374 Slc2a3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC2A3 mRNA CTD PMID:33387578 Slc2a3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC2A3 mRNA CTD PMID:16704738 more ... Slc2a3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc2a3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC2A3 mRNA CTD PMID:17872374 more ... Slc2a3 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC2A3 mRNA CTD PMID:11858732 and PMID:34747641 Slc2a3 Rat 2,4-D increases expression EXP 6480464 2 and 4-Dichlorophenoxyacetic Acid results in increased expression of SLC2A3 mRNA CTD PMID:23538319 Slc2a3 Rat 2,4-D decreases expression EXP 6480464 2 more ... CTD PMID:23538319 Slc2a3 Rat 2,6-di-tert-butyl-4-methylphenol decreases expression ISO Slc2a3 (Mus musculus) 6480464 Butylated Hydroxytoluene results in decreased expression of SLC2A3 mRNA CTD PMID:19925653 Slc2a3 Rat 2-deoxy-D-glucose increases transport ISO SLC2A3 (Homo sapiens) 6480464 SLC2A3 protein results in increased transport of Deoxyglucose CTD PMID:8457197 Slc2a3 Rat 2-deoxy-D-glucose multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 Cytochalasin B inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] more ... CTD PMID:8457197 Slc2a3 Rat 2-hydroxypropanoic acid affects expression ISO SLC2A3 (Homo sapiens) 6480464 Lactic Acid affects the expression of SLC2A3 mRNA CTD PMID:30851411 Slc2a3 Rat 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 Slc2a3 Rat 3,4-methylenedioxymethamphetamine increases expression ISO Slc2a3 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC2A3 mRNA CTD PMID:20188158 Slc2a3 Rat 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of SLC2A3 mRNA CTD PMID:23358152 Slc2a3 Rat 4,4'-sulfonyldiphenol increases expression ISO Slc2a3 (Mus musculus) 6480464 bisphenol S results in increased expression of SLC2A3 mRNA CTD PMID:30951980 Slc2a3 Rat 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO SLC2A3 (Homo sapiens) 6480464 Oxazolone results in increased expression of SLC2A3 mRNA CTD PMID:17374397 Slc2a3 Rat 5-fluorouracil affects response to substance ISO SLC2A3 (Homo sapiens) 6480464 SLC2A3 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 Slc2a3 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC2A3 mRNA CTD PMID:18077114 Slc2a3 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC2A3 mRNA CTD PMID:30047161 Slc2a3 Rat aflatoxin B1 decreases methylation ISO SLC2A3 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of SLC2A3 3' UTR and Aflatoxin B1 results in decreased methylation of SLC2A3 intron CTD PMID:30157460 Slc2a3 Rat aldehydo-D-glucose multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein more ... CTD PMID:28951307 and PMID:8457197 Slc2a3 Rat aldehydo-D-glucose multiple interactions EXP 6480464 [Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein and N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein] CTD PMID:24726522 Slc2a3 Rat all-trans-retinoic acid increases expression ISO SLC2A3 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC2A3 mRNA CTD PMID:16054129 and PMID:33167477 Slc2a3 Rat all-trans-retinoic acid decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SLC2A3 mRNA CTD PMID:16168501 Slc2a3 Rat alpha-D-galactose multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 Galactose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] more ... CTD PMID:8457197 Slc2a3 Rat alpha-D-galactose increases transport ISO SLC2A3 (Homo sapiens) 6480464 SLC2A3 protein results in increased transport of Galactose CTD PMID:8457197 Slc2a3 Rat amiodarone decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Amiodarone results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 more ... Slc2a3 Rat amitriptyline decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Amitriptyline results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 more ... Slc2a3 Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of SLC2A3 mRNA CTD PMID:30047161 Slc2a3 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC2A3 mRNA CTD PMID:16483693 Slc2a3 Rat ampicillin increases expression ISO SLC2A3 (Homo sapiens) 6480464 Ampicillin results in increased expression of SLC2A3 mRNA CTD PMID:21632981 Slc2a3 Rat antimonite multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA CTD PMID:32076005 Slc2a3 Rat antirheumatic drug decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of SLC2A3 mRNA CTD PMID:24449571 Slc2a3 Rat apigenin multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Apigenin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA CTD PMID:20153296 Slc2a3 Rat apigenin decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Apigenin results in decreased expression of SLC2A3 mRNA and Apigenin results in decreased expression of SLC2A3 protein CTD PMID:37437745 Slc2a3 Rat Archazolid B increases expression ISO SLC2A3 (Homo sapiens) 6480464 archazolid B results in increased expression of SLC2A3 mRNA CTD PMID:25218289 Slc2a3 Rat arsane multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC2A3 mRNA CTD PMID:32525701 Slc2a3 Rat arsenic atom multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC2A3 mRNA CTD PMID:32525701 Slc2a3 Rat arsenous acid increases expression ISO SLC2A3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC2A3 mRNA CTD PMID:22521957 and PMID:25258189 Slc2a3 Rat avobenzone increases expression ISO SLC2A3 (Homo sapiens) 6480464 avobenzone results in increased expression of SLC2A3 mRNA CTD PMID:31016361 Slc2a3 Rat Azoxymethane multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC2A3 mRNA CTD PMID:29950665 Slc2a3 Rat benzo[a]pyrene decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC2A3 mRNA CTD PMID:20106945 more ... Slc2a3 Rat benzo[a]pyrene affects methylation ISO SLC2A3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC2A3 intron CTD PMID:30157460 Slc2a3 Rat benzo[e]pyrene increases methylation ISO SLC2A3 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of SLC2A3 intron CTD PMID:30157460 Slc2a3 Rat Benzo[k]fluoranthene increases expression ISO Slc2a3 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of SLC2A3 mRNA CTD PMID:26377693 Slc2a3 Rat benzoates increases expression ISO SLC2A3 (Homo sapiens) 6480464 Benzoates analog results in increased expression of SLC2A3 mRNA CTD PMID:29472718 Slc2a3 Rat beta-lapachone increases expression ISO SLC2A3 (Homo sapiens) 6480464 beta-lapachone results in increased expression of SLC2A3 mRNA CTD PMID:38218311 Slc2a3 Rat beta-maltose multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] and Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose] CTD PMID:8457197 Slc2a3 Rat bis(2-ethylhexyl) phthalate increases expression ISO SLC2A3 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of SLC2A3 mRNA CTD PMID:31163220 Slc2a3 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein CTD PMID:37364641 Slc2a3 Rat bisphenol A increases expression ISO Slc2a3 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC2A3 mRNA CTD PMID:24909818 and PMID:26063408 Slc2a3 Rat bisphenol A multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein CTD PMID:37364641 Slc2a3 Rat bisphenol A increases expression ISO SLC2A3 (Homo sapiens) 6480464 bisphenol A results in increased expression of SLC2A3 mRNA CTD PMID:37080528 Slc2a3 Rat bisphenol A decreases methylation ISO SLC2A3 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of SLC2A3 gene CTD PMID:31601247 Slc2a3 Rat bisphenol A affects expression ISO SLC2A3 (Homo sapiens) 6480464 bisphenol A affects the expression of SLC2A3 mRNA CTD PMID:30903817 Slc2a3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC2A3 mRNA CTD PMID:25181051 and PMID:34947998 Slc2a3 Rat bisphenol A decreases expression ISO Slc2a3 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC2A3 mRNA and bisphenol A results in decreased expression of SLC2A3 protein CTD PMID:25637671 more ... Slc2a3 Rat bortezomib increases expression ISO SLC2A3 (Homo sapiens) 6480464 Bortezomib results in increased expression of SLC2A3 mRNA CTD PMID:20977926 Slc2a3 Rat bruceine D decreases expression ISO SLC2A3 (Homo sapiens) 6480464 bruceine D results in decreased expression of SLC2A3 protein CTD PMID:34900531 Slc2a3 Rat bruceine D multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 bruceine D affects the reaction [Oxygen deficiency affects the expression of SLC2A3 protein] and CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of SLC2A3 protein]] CTD PMID:34900531 Slc2a3 Rat buta-1,3-diene decreases expression ISO Slc2a3 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of SLC2A3 mRNA CTD PMID:21147608 Slc2a3 Rat butanal decreases expression ISO SLC2A3 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of SLC2A3 mRNA CTD PMID:26079696 Slc2a3 Rat Butylbenzyl phthalate multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein CTD PMID:37364641 Slc2a3 Rat cadmium atom decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Cadmium results in decreased expression of SLC2A3 mRNA CTD PMID:21120746 Slc2a3 Rat cadmium atom multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A3 mRNA CTD PMID:37325564 Slc2a3 Rat cadmium dichloride decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of SLC2A3 mRNA CTD PMID:26314618 Slc2a3 Rat cadmium dichloride multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A3 mRNA CTD PMID:37325564 Slc2a3 Rat cadmium dichloride increases expression ISO SLC2A3 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of SLC2A3 mRNA CTD PMID:38568856 Slc2a3 Rat cadmium dichloride increases expression ISO Slc2a3 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of SLC2A3 mRNA CTD PMID:30615929 Slc2a3 Rat cadmium dichloride multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SLC2A3 mRNA CTD PMID:12634122 Slc2a3 Rat cadmium dichloride increases methylation ISO Slc2a3 (Mus musculus) 6480464 Cadmium Chloride results in increased methylation of SLC2A3 promoter CTD PMID:27984135 Slc2a3 Rat cadmium dichloride decreases expression ISO Slc2a3 (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of SLC2A3 mRNA and Cadmium Chloride results in decreased expression of SLC2A3 protein CTD PMID:27984135 and PMID:37487938 Slc2a3 Rat caffeine increases expression ISO SLC2A3 (Homo sapiens) 6480464 Caffeine results in increased expression of SLC2A3 protein CTD PMID:25486098 Slc2a3 Rat caffeine affects phosphorylation ISO SLC2A3 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of SLC2A3 protein CTD PMID:35688186 Slc2a3 Rat calcitriol multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC2A3 mRNA CTD PMID:21592394 Slc2a3 Rat calcitriol increases expression ISO SLC2A3 (Homo sapiens) 6480464 Calcitriol results in increased expression of SLC2A3 mRNA CTD PMID:21592394 Slc2a3 Rat cannabidiol increases expression ISO SLC2A3 (Homo sapiens) 6480464 Cannabidiol results in increased expression of SLC2A3 mRNA CTD PMID:31518892 Slc2a3 Rat carbamazepine affects expression ISO SLC2A3 (Homo sapiens) 6480464 Carbamazepine affects the expression of SLC2A3 mRNA CTD PMID:25979313 Slc2a3 Rat chlorpromazine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Chlorpromazine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 Slc2a3 Rat chlorpyrifos increases expression ISO Slc2a3 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SLC2A3 mRNA CTD PMID:37019170 Slc2a3 Rat chromium atom multiple interactions EXP 6480464 Chromium inhibits the reaction [Dietary Fats results in decreased expression of SLC2A3 protein] CTD PMID:21120707 Slc2a3 Rat cisplatin increases phosphorylation ISO Slc2a3 (Mus musculus) 6480464 Cisplatin results in increased phosphorylation of SLC2A3 protein CTD PMID:22006019 Slc2a3 Rat cisplatin increases expression ISO SLC2A3 (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC2A3 mRNA CTD PMID:27594783 Slc2a3 Rat citalopram decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Citalopram results in decreased expression of SLC2A3 mRNA CTD PMID:17567588 Slc2a3 Rat clomipramine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Clomipramine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 and PMID:17175557 Slc2a3 Rat clozapine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Clozapine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 Slc2a3 Rat cobalt dichloride increases expression ISO SLC2A3 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of SLC2A3 mRNA CTD PMID:19320972 and PMID:19376846 Slc2a3 Rat copper atom multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A3 mRNA CTD PMID:25167922 Slc2a3 Rat copper(0) multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A3 mRNA CTD PMID:25167922 Slc2a3 Rat crocidolite asbestos increases expression ISO SLC2A3 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of SLC2A3 mRNA CTD PMID:25351596 Slc2a3 Rat curcumin decreases expression ISO Slc2a3 (Mus musculus) 6480464 Curcumin results in decreased expression of SLC2A3 mRNA CTD PMID:21397623 Slc2a3 Rat cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of SLC2A3 mRNA CTD PMID:19224547 Slc2a3 Rat cyclosporin A decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC2A3 mRNA CTD PMID:20106945 more ... Slc2a3 Rat cytochalasin B multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 Cytochalasin B inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] CTD PMID:8457197 Slc2a3 Rat D-glucose multiple interactions EXP 6480464 [Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein and N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein] CTD PMID:24726522 Slc2a3 Rat D-glucose multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein more ... CTD PMID:28951307 and PMID:8457197 Slc2a3 Rat decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC2A3 mRNA CTD PMID:23914054 Slc2a3 Rat decabromodiphenyl ether decreases expression ISO Slc2a3 (Mus musculus) 6480464 decabromobiphenyl ether results in decreased expression of SLC2A3 protein CTD PMID:28572024 and PMID:31039416 Slc2a3 Rat dextran sulfate multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC2A3 mRNA CTD PMID:29950665 Slc2a3 Rat Di-n-octyl phthalate multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein CTD PMID:37364641 Slc2a3 Rat diallyl trisulfide increases expression ISO SLC2A3 (Homo sapiens) 6480464 diallyl trisulfide results in increased expression of SLC2A3 mRNA CTD PMID:34995734 Slc2a3 Rat diarsenic trioxide increases expression ISO SLC2A3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC2A3 mRNA CTD PMID:22521957 and PMID:25258189 Slc2a3 Rat Dibutyl phosphate affects expression ISO SLC2A3 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SLC2A3 mRNA CTD PMID:37042841 Slc2a3 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SLC2A3 mRNA CTD PMID:21266533 Slc2a3 Rat dibutyl phthalate multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein CTD PMID:37364641 Slc2a3 Rat dibutyl phthalate increases expression ISO Slc2a3 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of SLC2A3 protein CTD PMID:36736749 Slc2a3 Rat dichromium trioxide multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SLC2A3 mRNA CTD PMID:12634122 Slc2a3 Rat diethyl phthalate multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein CTD PMID:37364641 Slc2a3 Rat Diisodecyl phthalate multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein CTD PMID:37364641 Slc2a3 Rat diisononyl phthalate decreases expression ISO Slc2a3 (Mus musculus) 6480464 diisononyl phthalate results in decreased expression of SLC2A3 mRNA CTD PMID:37482143 Slc2a3 Rat diisononyl phthalate multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein CTD PMID:37364641 Slc2a3 Rat dioxygen increases expression ISO Slc2a3 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of SLC2A3 mRNA CTD PMID:20880076 Slc2a3 Rat dioxygen affects expression ISO SLC2A3 (Homo sapiens) 6480464 Oxygen deficiency affects the expression of SLC2A3 protein CTD PMID:34900531 Slc2a3 Rat dioxygen increases expression ISO SLC2A3 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SLC2A3 mRNA and Oxygen deficiency results in increased expression of SLC2A3 protein CTD PMID:17442736 more ... Slc2a3 Rat dioxygen multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Apigenin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA more ... CTD PMID:17442736 more ... Slc2a3 Rat dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of SLC2A3 mRNA CTD PMID:23307114 Slc2a3 Rat dioxygen multiple interactions EXP 6480464 [Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein more ... CTD PMID:23307114 more ... Slc2a3 Rat dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA CTD PMID:32076005 Slc2a3 Rat divanadium pentaoxide affects expression ISO SLC2A3 (Homo sapiens) 6480464 vanadium pentoxide affects the expression of SLC2A3 mRNA CTD PMID:17459161 Slc2a3 Rat dorsomorphin multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Slc2a3 Rat doxepin decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Doxepin results in decreased expression of SLC2A3 mRNA CTD PMID:17567588 Slc2a3 Rat doxorubicin decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SLC2A3 mRNA CTD PMID:29803840 Slc2a3 Rat entinostat increases expression ISO SLC2A3 (Homo sapiens) 6480464 entinostat results in increased expression of SLC2A3 mRNA CTD PMID:26272509 Slc2a3 Rat entinostat multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat ethanol affects splicing ISO Slc2a3 (Mus musculus) 6480464 Ethanol affects the splicing of SLC2A3 mRNA CTD PMID:30319688 Slc2a3 Rat eugenol increases expression ISO SLC2A3 (Homo sapiens) 6480464 Eugenol results in increased expression of SLC2A3 mRNA CTD PMID:17374397 Slc2a3 Rat fisetin multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [fisetin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA CTD PMID:20153296 Slc2a3 Rat flecainide decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Flecainide results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 Slc2a3 Rat flecainide increases expression ISO SLC2A3 (Homo sapiens) 6480464 Flecainide results in increased expression of SLC2A3 mRNA CTD PMID:17175557 Slc2a3 Rat fluoxetine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Fluoxetine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 and PMID:17567588 Slc2a3 Rat folic acid multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SLC2A3 mRNA CTD PMID:22206623 Slc2a3 Rat formaldehyde increases expression ISO SLC2A3 (Homo sapiens) 6480464 Formaldehyde results in increased expression of SLC2A3 mRNA CTD PMID:27664576 Slc2a3 Rat galactose increases transport ISO SLC2A3 (Homo sapiens) 6480464 SLC2A3 protein results in increased transport of Galactose CTD PMID:8457197 Slc2a3 Rat galactose multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 Galactose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] more ... CTD PMID:8457197 Slc2a3 Rat gemcitabine increases expression ISO SLC2A3 (Homo sapiens) 6480464 Gemcitabine results in increased expression of SLC2A3 mRNA CTD PMID:17039268 Slc2a3 Rat genistein decreases expression EXP 6480464 Genistein results in decreased expression of SLC2A3 mRNA CTD PMID:21782745 Slc2a3 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC2A3 mRNA CTD PMID:33387578 Slc2a3 Rat glucose multiple interactions EXP 6480464 [Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein and N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein] CTD PMID:24726522 Slc2a3 Rat glucose multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein more ... CTD PMID:28951307 and PMID:8457197 Slc2a3 Rat imidacloprid increases expression EXP 6480464 imidacloprid results in increased expression of SLC2A3 mRNA CTD PMID:27782041 Slc2a3 Rat imipramine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Imipramine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 and PMID:17567588 Slc2a3 Rat ketoconazole decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Ketoconazole results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 and PMID:17567588 Slc2a3 Rat kynurenic acid multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 Kynurenic Acid inhibits the reaction [[INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein] CTD PMID:28951307 Slc2a3 Rat L-dehydroascorbic acid affects transport ISO SLC2A3 (Homo sapiens) 6480464 SLC2A3 protein affects the transport of Dehydroascorbic Acid CTD PMID:15590689 Slc2a3 Rat lead diacetate multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 mRNA more ... CTD PMID:12634122 and PMID:31874198 Slc2a3 Rat lead diacetate multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 protein CTD PMID:34508822 Slc2a3 Rat lead diacetate increases methylation EXP 6480464 lead acetate results in increased methylation of SLC2A3 gene CTD PMID:29571894 Slc2a3 Rat lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC2A3 mRNA and lead acetate results in increased expression of SLC2A3 protein CTD PMID:30980912 Slc2a3 Rat lead(0) multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 mRNA more ... CTD PMID:31874198 Slc2a3 Rat lead(0) multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 protein CTD PMID:34508822 Slc2a3 Rat lipopolysaccharide increases expression ISO SLC2A3 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of SLC2A3 mRNA CTD PMID:21362464 Slc2a3 Rat lipopolysaccharide multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC2A3 mRNA CTD PMID:35811015 Slc2a3 Rat loratadine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Loratadine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 and PMID:17567588 Slc2a3 Rat luteolin multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Luteolin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA CTD PMID:20153296 Slc2a3 Rat maltose multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] and Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose] CTD PMID:8457197 Slc2a3 Rat maneb multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of SLC2A3 mRNA CTD PMID:36117858 Slc2a3 Rat menadione decreases expression ISO Slc2a3 (Mus musculus) 6480464 Vitamin K 3 results in decreased expression of SLC2A3 mRNA CTD PMID:25270620 Slc2a3 Rat mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of SLC2A3 mRNA CTD PMID:23358152 Slc2a3 Rat mercury dibromide increases expression ISO SLC2A3 (Homo sapiens) 6480464 mercuric bromide results in increased expression of SLC2A3 mRNA CTD PMID:26272509 Slc2a3 Rat mercury dibromide multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of SLC2A3 mRNA CTD PMID:32599119 Slc2a3 Rat metacetamol decreases expression ISO Slc2a3 (Mus musculus) 6480464 3-hydroxyacetanilide results in decreased expression of SLC2A3 mRNA CTD PMID:18544908 Slc2a3 Rat methapyrilene increases methylation ISO SLC2A3 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of SLC2A3 intron CTD PMID:30157460 Slc2a3 Rat methotrexate affects expression ISO Slc2a3 (Mus musculus) 6480464 Methotrexate affects the expression of SLC2A3 mRNA CTD PMID:18502557 Slc2a3 Rat methotrexate decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Methotrexate results in decreased expression of SLC2A3 mRNA CTD PMID:24449571 Slc2a3 Rat methylmercury chloride decreases expression ISO SLC2A3 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SLC2A3 mRNA CTD PMID:23179753 and PMID:27188386 Slc2a3 Rat methylmercury chloride multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat methylmercury chloride increases expression ISO SLC2A3 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of SLC2A3 mRNA CTD PMID:23179753 more ... Slc2a3 Rat Monobutylphthalate increases expression ISO Slc2a3 (Mus musculus) 6480464 monobutyl phthalate results in increased expression of SLC2A3 protein CTD PMID:36736749 Slc2a3 Rat N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein] CTD PMID:24726522 Slc2a3 Rat N-acetyl-beta-D-glucosamine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Acetylglucosamine results in decreased expression of SLC2A3 mRNA CTD PMID:18047607 Slc2a3 Rat N-acetyl-beta-D-glucosamine increases expression ISO SLC2A3 (Homo sapiens) 6480464 Acetylglucosamine results in increased expression of SLC2A3 mRNA CTD PMID:18047607 Slc2a3 Rat N-acetyl-D-glucosamine increases expression ISO SLC2A3 (Homo sapiens) 6480464 Acetylglucosamine results in increased expression of SLC2A3 mRNA CTD PMID:18047607 Slc2a3 Rat N-acetyl-D-glucosamine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Acetylglucosamine results in decreased expression of SLC2A3 mRNA CTD PMID:18047607 Slc2a3 Rat N-acetyl-L-cysteine multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of SLC2A3 mRNA] and Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of SLC2A3 protein] CTD PMID:31857147 Slc2a3 Rat nickel atom increases expression ISO SLC2A3 (Homo sapiens) 6480464 Nickel results in increased expression of SLC2A3 mRNA CTD PMID:24768652 and PMID:25583101 Slc2a3 Rat nickel dichloride increases expression ISO SLC2A3 (Homo sapiens) 6480464 nickel chloride results in increased expression of SLC2A3 mRNA CTD PMID:17312168 Slc2a3 Rat nickel sulfate increases expression ISO SLC2A3 (Homo sapiens) 6480464 nickel sulfate results in increased expression of SLC2A3 mRNA CTD PMID:16780908 and PMID:17374397 Slc2a3 Rat niclosamide decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Niclosamide results in decreased expression of SLC2A3 mRNA CTD PMID:22576131 Slc2a3 Rat niclosamide increases expression ISO SLC2A3 (Homo sapiens) 6480464 Niclosamide results in increased expression of SLC2A3 mRNA CTD PMID:36318118 Slc2a3 Rat organoselenium compound multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A3 mRNA CTD PMID:25167922 Slc2a3 Rat oxaliplatin decreases expression ISO SLC2A3 (Homo sapiens) 6480464 oxaliplatin results in decreased expression of SLC2A3 mRNA CTD PMID:17762391 Slc2a3 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC2A3 mRNA CTD PMID:25729387 Slc2a3 Rat p-chloromercuribenzoic acid increases expression ISO SLC2A3 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of SLC2A3 mRNA CTD PMID:26272509 Slc2a3 Rat p-chloromercuribenzoic acid multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat panobinostat increases expression ISO SLC2A3 (Homo sapiens) 6480464 panobinostat results in increased expression of SLC2A3 mRNA CTD PMID:26272509 Slc2a3 Rat panobinostat multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat paracetamol decreases expression ISO Slc2a3 (Mus musculus) 6480464 Acetaminophen results in decreased expression of SLC2A3 mRNA CTD PMID:18544908 Slc2a3 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC2A3 mRNA CTD PMID:33387578 Slc2a3 Rat paracetamol decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC2A3 mRNA CTD PMID:17175557 Slc2a3 Rat paracetamol increases expression ISO SLC2A3 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC2A3 mRNA CTD PMID:21420995 Slc2a3 Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of SLC2A3 mRNA CTD PMID:18198484 Slc2a3 Rat paraquat multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of SLC2A3 mRNA CTD PMID:36117858 Slc2a3 Rat pentamidine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Pentamidine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 Slc2a3 Rat pentanal decreases expression ISO SLC2A3 (Homo sapiens) 6480464 pentanal results in decreased expression of SLC2A3 mRNA CTD PMID:26079696 Slc2a3 Rat perfluorooctane-1-sulfonic acid increases expression ISO Slc2a3 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of SLC2A3 protein CTD PMID:26178269 Slc2a3 Rat perfluorooctanoic acid decreases expression ISO SLC2A3 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of SLC2A3 protein CTD PMID:26879310 Slc2a3 Rat perhexiline decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Perhexiline results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 Slc2a3 Rat perhexiline increases expression ISO SLC2A3 (Homo sapiens) 6480464 Perhexiline results in increased expression of SLC2A3 mRNA CTD PMID:17175557 Slc2a3 Rat phenylmercury acetate multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat phenylmercury acetate increases expression ISO SLC2A3 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of SLC2A3 mRNA CTD PMID:26272509 Slc2a3 Rat pioglitazone multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA CTD PMID:20847119 Slc2a3 Rat potassium chromate multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC2A3 mRNA CTD PMID:22079256 Slc2a3 Rat potassium chromate increases expression ISO SLC2A3 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of SLC2A3 mRNA CTD PMID:22079256 Slc2a3 Rat potassium dichromate increases expression ISO Slc2a3 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of SLC2A3 mRNA CTD PMID:23608068 Slc2a3 Rat progesterone affects expression ISO Slc2a3 (Mus musculus) 6480464 Progesterone affects the expression of SLC2A3 mRNA CTD PMID:17251523 Slc2a3 Rat progesterone increases expression ISO Slc2a3 (Mus musculus) 6480464 Progesterone results in increased expression of SLC2A3 mRNA CTD PMID:22238285 Slc2a3 Rat progesterone multiple interactions EXP 6480464 Progesterone promotes the reaction [Oxygen deficiency results in increased expression of SLC2A3 mRNA] CTD PMID:23307114 Slc2a3 Rat purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of SLC2A3 mRNA CTD PMID:23358152 Slc2a3 Rat quercetin decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Quercetin results in decreased expression of SLC2A3 mRNA CTD PMID:21632981 Slc2a3 Rat quinidine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Quinidine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 and PMID:17567588 Slc2a3 Rat rac-lactic acid affects expression ISO SLC2A3 (Homo sapiens) 6480464 Lactic Acid affects the expression of SLC2A3 mRNA CTD PMID:30851411 Slc2a3 Rat raloxifene affects expression ISO SLC2A3 (Homo sapiens) 6480464 Raloxifene Hydrochloride affects the expression of SLC2A3 mRNA CTD PMID:14699072 Slc2a3 Rat resorcinol increases expression ISO SLC2A3 (Homo sapiens) 6480464 resorcinol results in increased expression of SLC2A3 mRNA CTD PMID:22623647 Slc2a3 Rat rotenone decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Rotenone results in decreased expression of SLC2A3 mRNA CTD PMID:36586010 Slc2a3 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC2A3 mRNA CTD PMID:35811015 Slc2a3 Rat SB 431542 increases expression ISO SLC2A3 (Homo sapiens) 6480464 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 protein CTD PMID:25670856 Slc2a3 Rat SB 431542 multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Slc2a3 Rat senecionine increases expression ISO Slc2a3 (Mus musculus) 6480464 senecionine results in increased expression of SLC2A3 protein CTD PMID:35357534 Slc2a3 Rat serpentine asbestos increases expression ISO SLC2A3 (Homo sapiens) 6480464 Asbestos and Serpentine results in increased expression of SLC2A3 mRNA CTD PMID:29523930 Slc2a3 Rat sertraline decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Sertraline results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 and PMID:17567588 Slc2a3 Rat silicon dioxide increases expression ISO SLC2A3 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of SLC2A3 mRNA CTD PMID:25351596 Slc2a3 Rat silicon dioxide decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of SLC2A3 mRNA CTD PMID:28425640 Slc2a3 Rat silicon dioxide increases expression ISO Slc2a3 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of SLC2A3 mRNA CTD PMID:29341224 Slc2a3 Rat sodium arsenate multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC2A3 mRNA CTD PMID:32525701 Slc2a3 Rat sodium arsenite multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SLC2A3 mRNA CTD PMID:12634122 Slc2a3 Rat sodium arsenite increases expression ISO SLC2A3 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC2A3 mRNA CTD PMID:34032870 Slc2a3 Rat sodium arsenite decreases expression ISO SLC2A3 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC2A3 mRNA CTD PMID:12634122 and PMID:29301061 Slc2a3 Rat sodium arsenite decreases expression ISO Slc2a3 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC2A3 mRNA CTD PMID:26876454 and PMID:37682722 Slc2a3 Rat sodium fluoride increases expression ISO Slc2a3 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of SLC2A3 protein CTD PMID:28918527 Slc2a3 Rat sotalol increases expression ISO SLC2A3 (Homo sapiens) 6480464 Sotalol results in increased expression of SLC2A3 mRNA CTD PMID:15342952 Slc2a3 Rat sotorasib multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC2A3 mRNA CTD PMID:36139627 Slc2a3 Rat sulforaphane increases expression ISO SLC2A3 (Homo sapiens) 6480464 sulforaphane results in increased expression of SLC2A3 mRNA CTD PMID:26833863 Slc2a3 Rat sunitinib increases expression ISO SLC2A3 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC2A3 mRNA CTD PMID:31533062 Slc2a3 Rat tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of SLC2A3 mRNA CTD PMID:19224547 Slc2a3 Rat tamoxifen affects expression ISO SLC2A3 (Homo sapiens) 6480464 Tamoxifen affects the expression of SLC2A3 mRNA CTD PMID:14699072 Slc2a3 Rat tamoxifen decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Tamoxifen results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 and PMID:17567588 Slc2a3 Rat tert-butyl hydroperoxide multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA more ... CTD PMID:20847119 Slc2a3 Rat tert-butyl hydroperoxide increases expression ISO SLC2A3 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA CTD PMID:20847119 Slc2a3 Rat testosterone multiple interactions ISO Slc2a3 (Mus musculus) 6480464 Testosterone inhibits the reaction [Testosterone deficiency results in decreased expression of SLC2A3 mRNA] CTD PMID:21045173 Slc2a3 Rat testosterone multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC2A3 mRNA CTD PMID:21592394 Slc2a3 Rat testosterone increases expression ISO SLC2A3 (Homo sapiens) 6480464 Testosterone results in increased expression of SLC2A3 mRNA CTD PMID:21592394 Slc2a3 Rat testosterone increases expression ISO Slc2a3 (Mus musculus) 6480464 Testosterone results in increased expression of SLC2A3 mRNA CTD PMID:20403060 Slc2a3 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC2A3 mRNA CTD PMID:16644059 Slc2a3 Rat tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of SLC2A3 mRNA CTD PMID:12734012 Slc2a3 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC2A3 mRNA CTD PMID:19224547 Slc2a3 Rat tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of SLC2A3 mRNA CTD PMID:19224547 Slc2a3 Rat thalidomide increases expression ISO Slc2a3 (Mus musculus) 6480464 Thalidomide results in increased expression of SLC2A3 mRNA CTD PMID:26217789 Slc2a3 Rat thimerosal decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Thimerosal results in decreased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat thioridazine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Thioridazine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 Slc2a3 Rat titanium dioxide multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC2A3 mRNA CTD PMID:29950665 Slc2a3 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of SLC2A3 mRNA CTD PMID:25729387 Slc2a3 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC2A3 mRNA CTD PMID:25729387 Slc2a3 Rat torcetrapib increases expression ISO SLC2A3 (Homo sapiens) 6480464 torcetrapib results in increased expression of SLC2A3 mRNA CTD PMID:23228038 Slc2a3 Rat trametinib multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC2A3 mRNA CTD PMID:36139627 Slc2a3 Rat tributylstannane decreases expression ISO SLC2A3 (Homo sapiens) 6480464 tributyltin results in decreased expression of SLC2A3 mRNA CTD PMID:19371601 Slc2a3 Rat trichostatin A increases expression ISO SLC2A3 (Homo sapiens) 6480464 trichostatin A results in increased expression of SLC2A3 mRNA CTD PMID:24935251 and PMID:26272509 Slc2a3 Rat trichostatin A affects expression ISO SLC2A3 (Homo sapiens) 6480464 trichostatin A affects the expression of SLC2A3 mRNA CTD PMID:28542535 Slc2a3 Rat trichostatin A multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat triclosan decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Triclosan results in decreased expression of SLC2A3 mRNA CTD PMID:30510588 Slc2a3 Rat triphenyl phosphate affects expression ISO SLC2A3 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SLC2A3 mRNA CTD PMID:37042841 Slc2a3 Rat Triptolide affects expression ISO Slc2a3 (Mus musculus) 6480464 triptolide affects the expression of SLC2A3 mRNA CTD PMID:34087332 Slc2a3 Rat Triptolide decreases expression ISO Slc2a3 (Mus musculus) 6480464 triptolide results in decreased expression of SLC2A3 mRNA and triptolide results in decreased expression of SLC2A3 protein CTD PMID:34087332 Slc2a3 Rat triptonide increases expression ISO Slc2a3 (Mus musculus) 6480464 triptonide results in increased expression of SLC2A3 mRNA CTD PMID:33045310 Slc2a3 Rat troglitazone multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA and troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA] CTD PMID:20847119 Slc2a3 Rat tungsten decreases expression ISO Slc2a3 (Mus musculus) 6480464 Tungsten results in decreased expression of SLC2A3 mRNA CTD PMID:30912803 Slc2a3 Rat tunicamycin increases expression ISO Slc2a3 (Mus musculus) 6480464 Tunicamycin results in increased expression of SLC2A3 mRNA CTD PMID:24370435 Slc2a3 Rat uranium atom affects expression ISO SLC2A3 (Homo sapiens) 6480464 Uranium affects the expression of SLC2A3 mRNA CTD PMID:15672453 Slc2a3 Rat urethane decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Urethane results in decreased expression of SLC2A3 mRNA CTD PMID:28818685 Slc2a3 Rat valproic acid increases expression ISO SLC2A3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC2A3 mRNA CTD PMID:23179753 more ... Slc2a3 Rat valproic acid multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat vandetanib increases expression ISO SLC2A3 (Homo sapiens) 6480464 vandetanib results in increased expression of SLC2A3 mRNA CTD PMID:16052530 Slc2a3 Rat vorinostat multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 Slc2a3 Rat vorinostat increases expression ISO SLC2A3 (Homo sapiens) 6480464 vorinostat results in increased expression of SLC2A3 mRNA CTD PMID:26272509 Slc2a3 Rat XL147 multiple interactions ISO Slc2a3 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC2A3 mRNA CTD PMID:27935865 Slc2a3 Rat Yessotoxin increases expression ISO SLC2A3 (Homo sapiens) 6480464 yessotoxin analog results in increased expression of SLC2A3 mRNA CTD PMID:30679557 Slc2a3 Rat zidovudine decreases expression ISO SLC2A3 (Homo sapiens) 6480464 Zidovudine results in decreased expression of SLC2A3 mRNA CTD PMID:24292225 Slc2a3 Rat zinc atom multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC2A3 mRNA CTD PMID:18593933 Slc2a3 Rat zinc(0) multiple interactions ISO SLC2A3 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC2A3 mRNA CTD PMID:18593933